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Highlights (for review)
Findings from this study suggest that depression is associated with the development of urinary 
incontinence symptom. It has a significant public health implication for the prevention and 
treatment of urinary incontinence. For instance when women in their twenty or thirties, seek 
advice or treatment on their UI symptoms, health professions should consider the possibility that 
depression and a history of depression may play a role in development of the condition
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ABSTRACT 
Objective: To examine the association of depressive symptoms with subsequent urinary 
incontinence (UI) symptoms among young women.
Subjects and Methods:
Data were from a cohort of 5391 young women (born 1973-78) from the Australian Longitudinal 
Study on Women’s Health. Generalised Estimating Equations (GEEs) were used to link 
depressive symptoms, and history of doctor diagnosed depression at Survey 2 (S2) in 2000 with 
the incidence of UI symptoms in subsequent surveys (from S3 in 2003 to S6 in 2012). 
Results: 24% of women reported the incidence of UI over the nine-year study period, while the 
prevalence rose over time from 6.8% (at S2, aged 22-27 years) to 16.5% (at S6, aged 34-39). 
From  univariable GEE analysis, women with depressive symptoms or a history of depression 
were more likely to report subsequent UI symptoms. This remained after adjusting for socio-
demographic, body mass index, health behaviours and reproductive factors, with depressive 
symptoms associated with 37% higher odds (odds ratio 1.37, 95% CI 1.16 to 1.61) and history of 
depression with 42% higher odds (1.42, 1.17 to 1.74) of incidence of UI.
Conclusions: When woman seek reatment for UI symptoms, health professionals should 
consider her current or history of depression.
Keywords: urinary incontinence symptoms; depression; cohort study; young women;
epidemiology
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1. Introduction
Urinary incontinence (UI) has a detrimental impact on quality of life and overall health 
perception [1-9], and is estimated to affect between 25% and 45% of Australian women [8].
Studies have established that depression and UI are often comorbid [10-16], but the role of 
depression as a cause or consequence of UI is less clear. Furthermore, previous studies have 
primarily focussed on mid-age and older women, with the result that much less is known of the 
aetiology of UI and links between depression and the condition among younger women [5].
Findings from studies of UI with a wide age range of women has shown that various socio-
demographic, and reproductive factors, and lifestyle factors, including being overweight or 
obese, having had a hysterectomy are associated with mixed (urge and stress) UI symptoms, 
while having given birth or being obese are linked with stress incontinence [4 8 9]. Depression, 
and superficially its temporal relationship with UI, was investigated by longitudinal study of 
mid-age women in the US that found the onset of UI was predicted by major depression at 
baseline, whereas UI did not increase the risk of subsequent depression [17]. This result is 
consistent with earlier research involving mid-age and older women, though the findings there
suggested that the relationship of depression related to subsequent stress UI rather than urge UI
[18 19].
This study draws on a decade of longitudinal data from a cohort of young Australian women to 
describe the prevalence of UI symptoms in this age group and to investigate the relationship 
between depression and subsequent reporting of UI symptoms, while controlling for a range of 
socio-demographic and reproductive factors, body mass index (BMI), and health behaviours.
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2. Methods
2.1 Study population
The Australian Longitudinal Study on Women’s Health (ALSWH) is a broad-ranging, national 
prospective study of factors affecting health and wellbeing of Australian women. In 1996, wide-
ranging baseline survey data were collected for more than 40000 women in three age cohorts: 
the 1973-78 cohort (aged 18 to 23 years in 1996) that is the subject of this study; the 1946-51 
cohort; and the 1921-26 cohort. Women in the 1996 sample were randomly selected from the 
national health insurance database (Medicare), which includes all Australian citizens and 
permanent residents. Women from rural and remote areas were deliberately oversampled. 
Informed consent was obtained from all participants, and approval was obtained from ethics 
committees at the University of Newcastle and the University of Queensland. Further details of
the recruitment methods and response rates have been described elsewhere [20].
2.2 Participants
The sample for this study is drawn from women in the 1973-78 cohort who provided data from 
survey 2 (S2) in 2000 onwards (as detailed symptoms of depression were not collected at the 
1996 baseline survey): S2 (n=9688), S3 in 2003 (n=9081), S4 in 2006 (n=9145), S5 in 2009 
(n=8200), and S6 in 2012 (n=7968). Less than five per cent of the women were excluded from 
the analysis due to omitting information on symptoms of urinary incontinence or depression. The 
final sample sizes in the current analysis were n= 9316, 8897, 8920, 7931 and 7809 for S2 to S6 
respectively, with a restricted sample of 6461 women who provided data at all five surveys. All 
variables listed below were ascertained at each survey unless indicated otherwise.
2.3 Study outcome
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At each survey S2 to S6, women were asked whether they had experienced leaking urine in the 
past 12 months. Response options were: never, rarely, sometimes, or often. Women were 
considered to have had UI symptoms at a particular survey only if they reported experiencing 
leaking urine ‘sometimes’, or ‘often’.
2.4 Exposure variables
Depressive symptoms.  These were measured using the Center for Epidemiologic Studies 
Depression Scale (CESD-10), a standardised scale designed to screen for depression symptoms 
experienced in the past week [21]. Scores range from 0 to 30, with scores 10 or higher indicating 
significant levels of depressive symptoms [21]. Thus, in the present study scores were 
dichotomised such that women were either identified as having depressive symptoms (CESD-10
scores of 10 and above) or not (scores below 10). 
History of depression. At S2 women were asked “have you ever been told by a doctor that you 
have depression: in the last four years, more than four years ago.” Women who provided an 
affirmative answer to either question were classified as having a history of depression. 
Antidepressant use. At S2, S3, and S4 women were asked if they had used prescription 
medication for depression in the past four weeks. At S5 women were asked to write down the 
names of all their medications that they have taken in the last four weeks and these were 
classified as antidepressant or not according to the Anatomical-Therapeutic-Chemical (ATC) 
drug classification system.
2.5 Covariates
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The following variables were included in the analysis as potentially confounding variables [1]
and were collected at every survey unless indicated otherwise: area of residence (urban, rural, or 
remote); highest educational attainment (year 12 or less, apprenticeship/certificate/diploma, 
university degree, or higher university degree); oral contraceptive pill use (yes or no); maternal 
age at first birth in years (nulliparous, less than 20 years, 20 to 25,  25.1 to 30 years, more than 
30.1 years); number of deliveries – reported at S6 – during which a vaginal tear requiring 
stitching occurred (0, 1, or 2 or more tears); and parity (0, 1, 2 or 3 or more children).
Body mass index (BMI) was calculated, from self-report weight and height, as weight (in kg) 
divided by height squared (in metres). BMIs were classified as: underweight (BMI <18.5), 
acceptable weight (BMI ≥18.5 and <25), overweight (BMI ≥25 and <30), obese (BMI ≥30) [9].
A physical activity score was derived from questions on frequency and total duration of various 
types of activity (inactive, low, moderate, high) [22]. Cigarette smoking was classified as none, 
past, or current smoker; and alcohol consumption as non-drinker, rarely, low-risk or risky, high-
risk drinker [23].
2.6 Data analysis
The prevalence of UI symptoms at each survey over the study period (S2 to S6) was calculated 
using the restricted sample of women from the cohort who responded to all five surveys with 
respect to UI symptoms and depression. 
The incidence of UI symptoms at a particular survey was defined by the presence of symptoms 
at that survey and absence of symptoms at all preceding surveys. Chi-squared analyses were 
used to compare the characteristics of women at S2 who developed UI symptoms between S3 
and S6 with those who remained symptom-free.
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Generalised estimating equation (GEE) models were then used to relate each of depressive 
symptoms, use of antidepressant, history of depression (at S2), socio-demographic
characteristics, reproductive factors, and BMI and health behaviours reported at S2 to S5 with 
the incidence of UI symptoms at the immediately subsequent survey (S3 to S6).  The GEE 
model was used to handle the multiple observations from each woman. The analyses were 
performed using the GENMOD procedure in SAS with a logit link function and an exchangeable 
correlation structure. Women without UI symptoms were considered as the reference category.
To obtain a fully adjusted model relating depression with the incidence of UI symptoms the 
analysis was carried out in a series of steps. First the univariable GEE analysis was repeated but 
using the restricted sample of women with responses on UI symptoms across all the surveys to 
identify unadjusted associations between the incidence of urinary incontinence and each 
exposure: depressive symptoms, history of depression, use of antidepressant; and confounding 
variables: socio-demographic factors, reproductive factors, BMI and health behaviours. Factors 
that were significant at the 10% level with the incidence of urinary incontinence were then 
selected for inclusion in the multivariable model to reveal the extent to which the effects of 
depression, history depression, and antidepressant use were associated with age and survey years 
(Model 1), then attenuated by reproductive factors (Model 2) and then attenuated further by 
socio-demographic factor, BMI, alcohol intake and physical activity level (Model 3). Statistical 
analysis was conducted using SAS version 9.2, and differences with p-values <0.05 were 
considered to be statistically significant.
3. Results
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From the restricted sample, the prevalence of UI symptoms (Figure 1) increased with age from 
6% at S2 when the women were aged 22-27 years to 16% by S6 (aged 34-39 years). Women
with depressive symptoms (CES-D ≥10), however, reported a consistently higher prevalence of 
UI symptoms, rising from 9% at S2 to more than 21% at S6.
Similar results were evident for the incidence of UI symptoms (Table 1), which were reported by 
one in four women (24.6%) between S3 and S6, with differences evident across a range of 
characteristics. A higher percentage of those with depressive symptoms (27% compared with 
22%, p<0.0001) or a history of depression (28% compared with 23%, p=0.001) developed UI 
symptoms between S3 and S6. In terms of potential confounders, difference in the percentage 
incidence of UI symptoms was also evident for educational attainment, age at first birth, parity, 
number of vaginal tears, use of oral contraceptive pill, BMI category, and physical activity level. 
Some evidence was found for differences in the incidence in UI symptoms according to alcohol 
intake (p=0.05).
Differences in incidence of UI symptoms were also quantified via univariable analysis (Table 2). 
Those with depressive symptoms were more likely to report UI symptoms between S3 to S6 
(Odds Ratio 1.30; 95% CI 1.16, 1.46), with a similar result for those with a history of depression 
(1.28; 1.11, 1.48). For confounding factors, women with children were more than twice as likely 
to report UI symptoms compared with nulliparous women; as was also evident for pregnant 
women (2.06; 1.87, 2.28). Women with vaginal tears had higher odds of reporting UI symptoms, 
with this odds rising with one tear (1.68; 1.49, 1.88) to two or more (1.79; 1.52, 2.11). Women in 
the overweight BMI category also had higher odds of reporting UI symptoms (1.25; 1.10, 1.42), 
with this odds increasing further for those in the obese category (1.32; 1.13, 1.53).
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Other factors were associated with lower odds of UI incidence among women. The level of 
educational attainment was associated with lower the likelihood of reporting UI symptoms, with 
those who had university degree qualifications at a lower odds (university degree 0.82; 0.72, 
0.93; higher degree 0.78; 0.67, 0.91) compared with women who had Year 12 or lower 
qualifications. Women with high physical activity level had one-third lower odds (0.64; 0.53, 
0.76) of reporting UI symptoms, compared with inactive women. A similar magnitude of 
difference was evident for those taking oral contraceptives (0.65; 0.58, 0.72). For alcohol 
consumption, only women who were low risk drinkers had lower odds of reporting UI symptoms 
(0.78 0.66, 0.93) compared with non-drinkers.
In the fully adjusted model (Table 3), which accounted for the effects of socio-demographic, 
reproductive, and health behaviour factors identified in the univariable analyses, women with
depressive symptoms or with a history of depression at S2 were more likely to develop UI 
symptoms in the subsequent surveys (OR 1.37; 1.16, 1.46; OR 1.42; 1.17,1.74 respectively).
4. Discussion
4.1 Main findings
Initial findings from the ALSWH 1973-78 cohort, indicated that women with depressive 
symptoms had a consistently higher prevalence of UI symptoms over the study period (from 
ages 22 to 27 years at S2 through to 34 to 39 years as S6) than women who did not report 
depressive symptoms. 
Further investigation into the temporal relationship of depression with the incidence of UI 
symptoms indicated that after adjusting for a range of confounding factors, women with
depressive symptoms at one survey had 37% higher likelihood of reporting UI symptoms in the 
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immediately following survey. Similar results were evident for women who reported a history of 
depression. These findings for young women are consistent with previous research that has 
implicated depression as a risk factor for subsequent urinary incontinence in mid-aged and older 
women [17-19].
4.2 Strengths and limitations 
The present study is strengthened by its ecological validity, due to the large, nationally 
representative sample and the longitudinal nature of the data, which allowed the comparison of 
symptoms over time. In addition, the prospective nature of data collection increased the accuracy 
of the current study’s data, as it reduced sources of error that may be present in research 
requiring long-term recall, for example, when mid-age and older women are asked to remember 
the circumstances surrounding the onset of urinary incontinence. In this study, surveys occurred 
at three-year intervals but asked the women about their experience of UI symptoms in the 
previous 12 months, leaving a two-year gap. So it is possible range that a higher level of UI 
incidence would have been recorded if the entire period between surveys had been covered at the 
expense of requiring a longer recall of symptoms, but if this had any impact it would have likely 
increased rather than weakened the associations identified.  A further strength of the study is the 
use of validated CESD-10 scale which is designed to measure depressive symptoms in the 
population. 
However, several methodological limitations of the study should be noted.  Women who had 
given birth or been pregnant less than one year prior to the survey time were excluded from the 
analyses.  Consequently, the study may have lacked sufficient power to detect some associations 
for instance between antidepressants use and UI symptoms.  Additionally, as it was a population 
based-study across large geographical areas, it was not possible to use a clinical diagnosis of 
urinary incontinence; instead UI symptoms were based on the participants’ reports on the 
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frequency of leaking urine. While we have categorised women who reported leaking urine 
“sometimes’ or “often” as indicative of the presence of UI symptoms, we obtained similar 
results when we only considered women who reported “often”.  Nonetheless our findings are 
consistent with previous studies on older women, a range of socio-demographic, reproductive 
factors, BMI, and health behaviours were also identified as associated with the incidence of UI 
symptoms [17-19].
4.3 Interpretation
The relationship between depression and urinary incontinence can be explained via several
possible mechanisms. Firstly, both depression and urinary urge incontinence may arise from
abnormalities in serotonin function. While a strong body of evidence supports a role of depleted 
serotonin levels in some types of depression [24-26], there is also a purported link between 
lower serotonin levels and enhanced bladder activity via the micturition reflex [27]. This link has 
been demonstrated in animal models [27 28]. Secondly, individuals with depression have been 
observed to have increased activation of the hypothalamic-pituitary pathway and the sympathetic 
nervous system [26]. Melville et al [17] speculate that over activation of these systems over a 
prolonged period, resulting in excess cortisol and catecholamines, might have a physiological 
impact on bladder function, which could potentially play a role in the experience of urinary 
incontinence. It may also be that depression and urinary incontinence are being caused by a 
common neurochemical pathogenesis, since antidepressant medications such as duloxetine is 
known to manage both symptoms [29 30]. Another explanation could be that women with 
depressive symptoms were more likely to report UI symptoms although we have minimised the
effect by considering depressive symptoms at survey prior to the report of UI symptoms.
5. Conclusions
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Findings from this study suggest that depression is associated with the development of urinary 
incontinence symptom. It has a significant public health implication for the prevention and 
treatment of urinary incontinence. For instance when women in their twenty or thirties, seek 
advice or treatment on their UI symptoms, health professions should consider the possibility that 
depression and a history of depression may play a role in development of the condition.
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Figure captions 
Figure 1 Percentage of women reporting of urinary incontinence symptoms in surveys 2 – 6 by 
Center for Epidemiologic Studies Depression Scale (CES-D) scores (n =6461)
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Table 1 Characteristics of women at Survey 2 (aged 22-27) and incidence of urinary 
incontinence between Surveys 3 and 6
Characteristic N UI symptom-
free
Incidence of 
UI symptoms
p-value
Depression <0.0001
CES-D 10 <10 4728 78.0 22.0
CES-D 10 ≥10 1733 73.1 27.0
History of depression 0.001
No 5749 77.4 22.6
Yes 852 72.3 27.7
Use of antidepressants 0.06
No 6306 77.0 23.0
Yes 269 72.1 27.9
Area of residence 0.104
Urban 3726 77.4 22.6
Rural 2664 76.2 23.8
Remote 246 72.0 28.1
Educational attainment 0.015
Year 12 or less 1997 75.5 24.5
Apprenticeship/Certificate/
Diploma
1535 75.2 24.8
University Degree 2497 78.8 21.2
Higher University Degree 439 78.6 21.4
Age at first birth, years <0.0001
Nulliparous 1843 90.7 9.3
Less than 20.0 235 78.7 21.3
20.0 to 25.0 792 77.0 23.0
25.1 to 30.0 1989 73.9 26.1
30.1 to 36.0 2306 78.9 21.1
Parity
Nulliparous 4702 80.9 19.1 <0.0001
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1 981 73.0 27.0
2 630 70.8 29.2
3 or more 229 71.2 28.8
Number of vaginal tears <0.0001
0 2607 82.1 17.9
1 2066 72.6 27.4
2 or more 685 69.2 30.8
Oral contraceptive pill use <0.0001
No 3065 76.4 23.6
Yes 3218 80.6 19.4
Body mass index <0.0001
Underweight 398 82.4 17.6
Acceptable weight 3963 78.1 21.9
Overweight 1199 76.0 24.0
Obese 588 71.1 28.9
Physical activity levels 0.003
Inactive 581 70.9 29.1
Low 2244 76.6 23.4
Moderate 1586 77.7 22.3
High 2114 78.1 22.0
Smoking status 0.166
Never 4006 77.6 22.4
Ex-smoker 922 75.2 24.8
Current smoker 1690 75.9 24.1
Alcohol intake 0.050
Non-drinker 4094 77.8 22.3
Low risk drinker 509 72.9 27.1
Rarely drinks 1785 75.7 24.3
Risky drinkers 244 75.4 24.6
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Table 2 Unadjusted odds ratios (95% confidence intervals) for the risk of developing urinary 
incontinence symptoms over successive surveys from 3 to 6 in young women (n=24,939
observations)
Characteristic Odds ratio p-value
Age (SD) (y) 1.10 (1.06, 1.13) <0.001
Depression <0.001
CES-D 10 <10 Reference
CES-D 10 ≥10 1.30 (1.16, 1.46)
History of depression 0.0007
No Reference
Yes 1.28 (1.11, 1.48)
Use of antidepressant 0.3
No Reference
Yes 1.12 (0.90 – 1.40)
Area of residence 0.006
Urban Reference
Rural 1.18 (1.07, 1.30)
Remote 1.09 (0.85, 1.39)
Educational attainment 0.0002
Year 12 or less Reference
Apprenticeship/Certificate/Diploma 0.99 (0.87, 1.13)
University Degree 0.82 (0.72, 0.93)
Higher University Degree 0.78 (0.67, 0.91)
Age at first birth, years <0.001
Nulliparous Reference
Less than 20.0 2.91 (2.18, 3.88)
20.0 to 25.0 2.82 (2.31, 3.44)
25.1 to 30.0 3.09 (2.92, 3.64)
30.1 to 36.0 2.39 (2.03, 2.81)
Parity <0.0001
Nulliparous Reference
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1 1.57 (1.19, 2.08)
2 2.16 (1.67, 2.80)
3 or more 2.30 (1.76, 3.01)
Number of vaginal tear <0.0001
0 Reference
1 1.68 (1.49, 1.88)
2 or more 1.79 (1.52, 2.11)
Oral contraceptive pill use <0.0001
No Reference
Yes 0.65 (0.58, 0.72)
Body mass index 0.0001
Underweight 0.88 (0.65, 1.19)
Healthy Weight Reference
Overweight 1.25 (1.10, 1.42)
Obese / Very Obese 1.32 (1.13, 1.53)
Physical activity levels <0.001
Inactive Reference
Low 0.82 (0.70, 0.97)
Moderate 0.75 (0.63, 0.90)
High 0.64 (0.53, 0.76)
Smoking status 0.5
Never Reference
Ex-smoker 1.07 (0.94, 1.22)
Current smoker 0.97 (0.85, 1.12)
Alcohol intake 0.003
Non-drinker Reference
Low risk drinker 0.78 (0.66, 0.93)
Rarely drinks 0.93 (0.77, 1.12)
Risky drinkers 1.02 (0.76, 1.37)
Pregnancy status <0.001
Not Pregnant Reference
Pregnant 2.06 (1.87, 2.28)
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Table 3 Odds ratios (95% confidence intervals) for the associations between depression (depressive symptoms and history of depression†) at
Surveys 2 to 5 and the risk of having urinary incontinence symptoms from Surveys 3 to 6 among young women (n=12450 observations)
Risk factors Model 1 Model 2 Model 3
Odds ratio p-value Odds ratio p-value Odds ratio p-value
Depressive symptoms at 
preceding survey
0.0001 0.0002 0.0004
CES-D 10 <10 Reference Reference Reference
CES-D 10 ≥10 1.38 (1.19, 1.62) 1.38 (1.18, 1.62) 1.37 (1.16, 1.61)
History of depression 0.0002 0.0005 0.001
No Reference Reference Reference
Yes 1.49 (1.24, 1.80) 1.45 (1.20, 1.76) 1.42 (1.17, 1.74)
†history of depression was only asked at survey 2.
Model 1: adjusted for age and survey year
Model 2: includes depression, history of depression and adjusted for age, survey, reproductive factors (oral contraceptive pill use; currently 
pregnant, age at first birth and number of vaginal tears); Model 3: all variables in model 1 and education, area of residence, body mass index, 
alcohol intake, and physical activity level.
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